Novalung System

Novalung System is an FDA 510(k)-cleared medical device (K191407) manufactured by Fresenius Medical Care Renal Therapies Group, LLC. This device is classified under the Cardiovascular specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on February 20, 2020. Regulation: 8.